Prophylactic evaluation of verubecestat on disease‐ and symptom‐modifying effects in 5XFAD mice is a research paper published in Alzheimer s & Dementia Translational Research & Clinical Interventions (2022). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 7RF1AG051495-02
Central and Peripheral Roles of TREM2 in Alzheimer's Disease
National Institutes of Health
Grant: 2R01AG022304-06A2
fMRI as an Imaging Biomarker for Preclinical Alzheimer's Disease
National Institutes of Health
Grant: 3P30CA082709-16S3
Indiana University Melvin and Bren Simon Cancer Center Support Grant
National Institutes of Health
Grant: 5U54AG065181-03
IUSM Alzheimer's Disease Drug Discovery Center
National Institutes of Health
Grant: 3U54AG054345-05S1
IU/JAX/Pitt MODEL-AD: Deep Phenotyping Metabolomics Year 1
National Institutes of Health
Grant: 5K01AG054753-03
In vivo assessment of the role of neurons and glia in tau propagation
FWCI
1.54
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals